Article | October 12, 2022

Decentralized Clinical Trials Are Closer Than You Think

Source: Merative

By Jennifer Duff, General Manager, Clinical Development Solutions

GettyImages-1278681737 decentralized trials

A decentralized clinical trial (DCT) is a popular buzzword right now, but behind the buzz is the usual mix of noise and confusion. For example, a DCT doesn’t mean decentralizing everything. In fact, fully decentralized or virtual trials are relatively rare. Far more common is a hybrid approach that mixes elements of both on-site and remote capabilities. For example, a more realistic DCT study may feature electronic consent (e-consent), data collected directly from wearable devices, televisits and sample collection at a local pharmacy, while still requiring a portion of research data to be captured during specific visits to an investigator site.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader